Immunome, Inc.
(NASDAQ CM: IMNM)
Rigrodsky Law, P.A. is investigating Immunome, Inc. (“Immunome”) regarding possible breaches of fiduciary duties and other violations of law related to Immunome’s agreement to merge with Morphimmune.
(NASDAQ CM: IMNM)
Rigrodsky Law, P.A. is investigating Immunome, Inc. (“Immunome”) regarding possible breaches of fiduciary duties and other violations of law related to Immunome’s agreement to merge with Morphimmune.